Karen Luyt

Karen Luyt

Auto-generated profile, based on publicly available information

Karen Luyt

Bristol Medical School, University of Bristol, United Kingdom

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Neonatology
Verified
Journal Article
Closed access
MTMarianne Thoresen
Marianne Thoresen
JTJames Tooley
James Tooley
XLXun Liu
Xun Liu
SJSally Jary
Sally Jary
PFPeter Fleming
Peter Fleming
HSHemmen Sabir
Hemmen Sabir
Objective: Therapeutic hypothermia (HT) is the standard treatment for newborns after perinatal asphyxia. Preclinical studies report that HT is more effective when started early. Methods: Eighty cooled newborns were analyzed and grouped according to when cooling was started after birth: early (≤180 min) or late (>181 min). For survivors we analyzed whether starting cooling early was associated with a better psychomotor or mental developmental index (PDI or MDI, Bayley Scales of Infant Development II) than late cooling. Results: Forty-three newborns started cooling early and 37 started late. There was no significant difference in the severity markers of perinatal asphyxia between the groups; however, nonsurvivors (n = 15) suffered more severe asphyxia and had significantly lower centiles for weight (BWC; p = 0.009). Of the 65 infants that survived, 35 were cooled early and 30 were cooled late. There was no difference in time to start cooling between those who survived and those who did not. For survivors, median PDI (IQR) was significantly higher when cooled early [90 (77-99)] compared to being cooled later [78 (70-90); p = 0.033]. There was no increase in cardiovascular adverse effects in those cooled early. There was no significant difference in MDI between early and late cooling [93 (77-103) vs. 89 (76-106), p = 0.594]. Conclusion: Starting cooling before 3 h of age in surviving asphyxiated newborns is safe and significantly improves motor outcome. Cooling should be initiated as soon as possible after birth in eligible infants.

11 November 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
CSClare Smith
Clare Smith
DODavid Odd
David Odd
RHRachel Harwood
Rachel Harwood
JWJoseph Ward
Joseph Ward
MLMike Linney
Mike Linney
LFLorna Fraser
Lorna Fraser


5 October 2006 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
KLKaren Luyt
Karen Luyt
TSTimothy P. Slade
Timothy P. Slade
JDJienchi Dorward
Jienchi Dorward
CDClaire F. Durant
Claire F. Durant
YWYue Wu
Yue Wu
Elek MolnárElek Molnár
Elek Molnár

24 April 2019 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
SPSilvia Pregnolato
Silvia Pregnolato
ECElavazhagan Chakkarapani
Elavazhagan Chakkarapani
AIAnthony R. Isles
Anthony R. Isles
KLKaren Luyt
Karen Luyt
Preterm birth complications are the leading cause of child death worldwide and a top global health priority. Among the survivors, the risk of life-long disabilities is high, including cerebral palsy and impairment of movement, cognition, and behavior. Understanding the molecular mechanisms of preterm brain injuries is at the core of future healthcare improvements. Glutamate excitotoxicity is a key mechanism in preterm brain injury, whereby the accumulation of extracellular glutamate damages the delicate immature oligodendrocytes and neurons, leading to the typical patterns of injury seen in the periventricular white matter. Glutamate excitotoxicity is thought to be induced by an interaction between environmental triggers of injury in the perinatal period, particularly cerebral hypoxia-ischemia and infection/inflammation, and developmental and genetic vulnerabilities. To avoid extracellular build-up of glutamate, the brain relies on rapid uptake by sodium-dependent glutamate transporters. Astrocytic excitatory amino acid transporter 2 (EAAT2) is responsible for up to 95% of glutamate clearance, and several lines of evidence suggest that it is essential for brain functioning. While in the adult EAAT2 is predominantly expressed by astrocytes, EAAT2 is transiently upregulated in the immature oligodendrocytes and selected neuronal populations during mid-late gestation, at the peak time for preterm brain injury. This developmental upregulation may interact with perinatal hypoxia-ischemia and infection/inflammation and contribute to the selective vulnerability of the immature oligodendrocytes and neurons in the preterm brain. Disruption of EAAT2 may involve not only altered expression but also impaired function with reversal of transport direction. Importantly, elevated EAAT2 levels have been found in the reactive astrocytes and macrophages of human infant post-mortem brains with severe white matter injury (cystic periventricular leukomalacia), potentially suggesting an adaptive mechanism against excitotoxicity. Interestingly, EAAT2 is suppressed in animal models of acute hypoxic-ischemic brain injury at term, pointing to an important and complex role in newborn brain injuries. Enhancement of EAAT2 expression and transport function is gathering attention as a potential therapeutic approach for a variety of adult disorders and awaits exploration in the context of the preterm brain injuries.

17 July 2006 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
KLKaren Luyt
Karen Luyt
AVAnikó Váradi
Anikó Váradi
CDClaire F. Durant
Claire F. Durant
Elek MolnárElek Molnár
Elek Molnár